Also known as: Urticaria (Acute and Chronic)
Urticaria presents as raised, itchy welts on the skin.
Urticaria, commonly known as hives, is a prevalent skin condition characterized by the sudden appearance of raised, itchy welts (wheals) on the skin. These welts result from the release of histamine and other chemical mediators from mast cells in the skin, causing localized swelling, redness, and intense itching. Urticaria is classified as acute (lasting less than 6 weeks) or chronic (persisting for 6 weeks or longer). Acute urticaria is extremely common, affecting approximately 15-25% of people at least once in their lifetime, while chronic urticaria affects about 1-5% of the population.
Acute urticaria frequently has an identifiable trigger. Common causes include allergic reactions to foods (shellfish, nuts, eggs, milk), medications (antibiotics, NSAIDs, ACE inhibitors), insect stings, latex exposure, and viral or bacterial infections. Physical stimuli such as cold, heat, pressure, sunlight, or exercise can also provoke hives (physical urticaria). In contrast, chronic urticaria often has no identifiable external cause. In approximately 40-60% of chronic cases, the condition is autoimmune in nature, with the body producing autoantibodies against IgE receptors on mast cells, leading to spontaneous histamine release.
Individual hives typically appear within minutes, last for several hours (usually less than 24 hours), and resolve without leaving any mark or bruise. However, new welts continuously appear as old ones fade, giving the impression of a persistent rash. Urticaria can occur with angioedema, a deeper swelling affecting the lips, eyelids, tongue, hands, feet, or genitalia. When hives are associated with systemic symptoms such as breathing difficulty, throat swelling, or hemodynamic instability, the condition may represent anaphylaxis, a medical emergency requiring immediate treatment with epinephrine.
People with Urticaria (Hives) often experience the following symptoms.
The defining feature of urticaria is the sudden appearance of raised, well-circumscribed welts on the skin. These wheals are typically round or oval, range in size from a few millimeters to several centimeters, and may merge to form larger plaques. They are red on lighter skin and may appear lighter or darker than surrounding skin on deeper skin tones.
Hives are accompanied by intense itching that can be maddening and difficult to ignore. The itching may range from mild to debilitating and tends to worsen in the evening and at night. Heat, sweating, and friction can exacerbate the itch. Some patients describe a burning or stinging quality rather than pure itch.
A characteristic feature of urticaria is that individual welts are transient — they typically resolve within 2-24 hours while new ones appear elsewhere. This migratory pattern, where the rash seems to move around the body, distinguishes urticaria from many other skin conditions with fixed lesions.
Approximately 40% of urticaria patients also experience angioedema, a deeper swelling of the subcutaneous and submucosal tissues. It most commonly affects the face (lips, eyelids), tongue, hands, feet, and genitalia. Angioedema is often asymmetric, may be painful rather than itchy, and takes longer to resolve (up to 72 hours).
When pressed firmly, urticarial welts blanch (turn white) and then return to their red color when pressure is released. This blanching quality helps distinguish urticaria from purpura or vasculitic lesions, which do not blanch because they involve bleeding into the skin.
Many patients with urticaria exhibit dermatographism (skin writing), where gentle scratching or stroking of the skin produces a wheal-and-flare response along the scratched line. This physical form of urticaria affects approximately 5% of the general population and is the most common type of physical urticaria.
In some cases, particularly when urticaria is part of an allergic reaction, patients may experience accompanying symptoms such as abdominal pain, nausea, headache, or a general sense of malaise. Severe systemic symptoms including breathing difficulty or circulatory changes indicate possible anaphylaxis.
Certain factors may increase your likelihood of developing Urticaria (Hives).
Common approaches to managing urticaria (hives). Always consult a healthcare provider for personalized treatment.
Non-sedating antihistamines such as cetirizine, loratadine, or fexofenadine are the first-line treatment for urticaria. They block H1 histamine receptors, reducing itching and wheal formation. Standard doses are tried first, and guidelines recommend increasing the dose up to four times the standard dose before considering additional therapies.
For chronic spontaneous urticaria that does not respond to high-dose antihistamines, omalizumab is an injectable biologic therapy that binds free IgE, reducing mast cell activation. Administered monthly by injection, it has shown excellent efficacy with 65-90% of patients achieving complete or near-complete symptom control.
Brief courses of oral prednisone (3-7 days) may be used for severe acute urticaria flares or angioedema. Corticosteroids rapidly suppress the immune response and reduce swelling. They are not recommended for long-term use due to significant side effects including weight gain, osteoporosis, and adrenal suppression.
Patients with urticaria associated with anaphylaxis risk (history of severe reactions, known food or drug allergies) should carry an epinephrine auto-injector (EpiPen) at all times. Epinephrine is the first-line emergency treatment for anaphylaxis and should be administered immediately at the first signs of a severe systemic reaction.
Identifying and avoiding triggers is fundamental to managing urticaria. This may involve eliminating specific food allergens, substituting triggering medications, avoiding physical stimuli (cold, pressure, heat), managing stress, and treating underlying infections. Keeping a detailed symptom diary can help identify patterns and triggers.
For refractory chronic urticaria, additional options include cyclosporine (an immunosuppressant), leukotriene receptor antagonists (montelukast), dapsone, or other immunomodulatory agents. These are considered third-line options and require specialist supervision due to potential side effects.
Diagnosing urticaria is primarily clinical, based on the characteristic appearance of transient, itchy wheals. The physician takes a detailed history including timing, duration, potential triggers (foods, medications, infections, physical stimuli), associated angioedema, and personal or family history of allergies. Physical examination assesses the distribution, morphology, and behavior of the welts. For acute urticaria, the cause is often identifiable through history. For chronic urticaria lasting more than 6 weeks, laboratory evaluation may include a complete blood count, erythrocyte sedimentation rate, C-reactive protein, thyroid function tests, and autologous serum skin test or basophil activation test to evaluate for autoimmune urticaria. Allergy testing (skin prick tests or specific IgE) may be performed if a specific allergen is suspected. Skin biopsy is reserved for atypical presentations to rule out urticarial vasculitis, where wheals last longer than 24 hours, leave bruising, and are more painful than itchy.
Seek emergency medical care immediately if hives are accompanied by difficulty breathing, throat tightness or swelling, dizziness or lightheadedness, rapid heartbeat, or nausea and vomiting, as these may indicate anaphylaxis — a life-threatening allergic reaction requiring epinephrine.
Steps that may help reduce the risk of developing or worsening urticaria (hives).
Identify and strictly avoid known triggers including specific foods, medications, and environmental allergens that provoke hives
Wear loose-fitting, breathable clothing and avoid tight belts, straps, or garments that create sustained pressure on the skin
Manage emotional and physical stress through relaxation techniques, as stress is a well-documented trigger for chronic urticaria
Keep skin cool and avoid overheating, as heat and sweating can trigger or worsen hives in many individuals
Carry an epinephrine auto-injector if you have a history of severe allergic reactions or anaphylaxis associated with hives
If left untreated or poorly managed, urticaria (hives) may lead to:
Individual hive welts typically last between 30 minutes and 24 hours before fading without leaving any mark. However, new welts may continue to appear as old ones resolve, making the overall episode last longer. Acute urticaria (the most common form) usually resolves within days to a few weeks. If hives persist or recur for more than 6 weeks, the condition is classified as chronic urticaria, which may last months to years but eventually resolves in most patients.
Yes, stress is a well-recognized trigger for urticaria. Psychological stress causes the release of neuropeptides and hormones including cortisol and substance P, which can activate mast cells and trigger histamine release. Stress-induced hives are particularly common in individuals with chronic urticaria. Managing stress through exercise, meditation, cognitive behavioral therapy, or other relaxation techniques may help reduce the frequency and severity of stress-related flare-ups.
Go to the emergency room immediately if hives are accompanied by any of the following: difficulty breathing or wheezing, swelling of the tongue, throat, or lips, feeling faint or dizzy, rapid heartbeat, nausea, vomiting, or abdominal cramping, or a sense of impending doom. These symptoms suggest anaphylaxis, which requires immediate treatment with epinephrine. If you carry an EpiPen, use it right away and still proceed to the emergency room.
Acute urticaria lasts less than 6 weeks and usually has an identifiable trigger such as a food allergy, medication reaction, or infection. It is very common and typically resolves on its own or with short-term antihistamine use. Chronic urticaria persists for 6 weeks or longer and often has no identifiable external cause. Chronic spontaneous urticaria is frequently autoimmune in origin and may require long-term treatment with high-dose antihistamines or biologic therapy like omalizumab.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.